Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 1-A POS Offering statement (post-effective amendment)
- PART II AND III Preliminary Offering Circular
- EX1A-2A CHARTER Engagement Agreement, Dated May 18, 2020, Between 20/20 Genesystems, Inc. and Si Securities, LLC
- EX1A-4 SUBS AGMT Form of Subscription Agreement for Series C Preferred Stock (Si Securities, LLC)
- EX1A-8 ESCW AGMT Escrow Agreement, Dated June 17, 2020, Among Si Securities, LLC, 20/20 Genesystems, Inc. and the Bryn Mawr Trust Company of Delaware
- EX1A-11 CONSENT Consent of Dbbmckennon
Associated filings
- 25 May 21 253G2 Offering circular supplement
- 26 Feb 21 253G2 Offering circular supplement
- 5 Oct 20 253G2 Offering circular supplement
- 5 Oct 20 253G2 Offering circular supplement
- 20 Jul 20 253G1 Information omitted from offering circular
- 20 Jul 20 QUALIF Notice of qualification
-
8 Jul 20 1-A POS Offering $14.7M in Equity
- 23 Jun 20 253G2 Offering circular supplement
- 6 Apr 20 253G2 Offering circular supplement
- 20 Mar 20 253G2 Offering circular supplement
- 9 Jan 20 253G1 Information omitted from offering circular
- 9 Jan 20 QUALIF Notice of qualification
- 31 Dec 19 1-A/A Offering $14.7M in Equity
Filing view
External links